Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)Axel Grothey, Hans‐Joachim Schmoll, Hendrik Kroening et al.|European Journal of Cancer|2001Cited by 57